CommunICation of bEnefit Risk Information: an Online Randomised Controlled Trial
CICERO
1 other identifier
interventional
2,178
1 country
1
Brief Summary
How health-related information is communicated affects what is understood and might influence how people make decisions and how confident they feel in participating in clinical shared decision-making. The CICERO trial will compare three different communication tools providing information on fictional interventions for a common medical problem (i.e. social anxiety disorder) both in terms of how well interventions work (benefit) and also possible harms associated (risk). The three communication tools ("Summary of Findings table", "Kilim plot", and "Vitruvian plot") differ in how they present information: exclusively written, primarily written and partially graphical, or mixed written and visual. Each participant will be asked to go through one clinical scenario. The investigators will ask participants to familiarise themselves with the tool they have been allocated to (either a plot or a table) and then answer some validated questionnaires to measure how useful and efficient the communication strategy was. The entire study occurs online in a single study session (about 20 minutes). The results of the CICERO trial will inform how to communicate research findings to the general population, facilitating their implementation in clinical shared decision-making.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 31, 2023
CompletedFirst Submitted
Initial submission to the registry
June 5, 2023
CompletedFirst Posted
Study publicly available on registry
June 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 27, 2023
CompletedDecember 18, 2023
December 1, 2023
6 months
June 5, 2023
December 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Decisional Conflict Scale, low literacy version
Higher scores indicate worse outcomes (min = 0; max = 100).
through study completion, an average of 20 minutes
Secondary Outcomes (3)
Decision Self-Efficacy scale
through study completion, an average of 20 minutes
Preparation for Decision Making scale
through study completion, an average of 20 minutes
Information comprehension (proportion of participants providing a correct answer)
through study completion, an average of 20 minutes
Other Outcomes (1)
Number of minutes to complete the questionnaire
through study completion, an average of 20 minutes
Study Arms (3)
Vitruvian plot
EXPERIMENTALKilim plot
EXPERIMENTALSummary of findings table
ACTIVE COMPARATORInterventions
Visual (magnitude, uncertainty) and written (magnitude) communication tool / interventional decision-making aid tool
Visual (uncertainty) and written (magnitude) communication tool / interventional decision-making aid tool
Written (magnitude, uncertainty) communication tool / interventional decision-making aid tool
Eligibility Criteria
You may qualify if:
- aged between 18 and 65 years (inclusive)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oxford Precision Psychiatry Lab (OxPPL)
Oxford, United Kingdom
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2023
First Posted
June 26, 2023
Study Start
May 31, 2023
Primary Completion
November 27, 2023
Study Completion
November 27, 2023
Last Updated
December 18, 2023
Record last verified: 2023-12